Dublin, Jan. 19, 2017 -- Research and Markets has announced the addition of the "Implantable Biomaterials Market Analysis & Trends - Material, Application - Forecast to 2025" report to their offering.
The Global Implantable Biomaterials Market is poised to grow at a CAGR of around 7.5% over the next decade to reach approximately $165.31 billion by 2025.
This industry report analyzes the global markets for Implantable Biomaterials across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Some of the prominent trends that the market is witnessing include increasing geriatric population, growing incidences of diseases & graft transplant surgeries and medical implants and technological advancements.
Based on Material the market is categorized into immunomodulatory biomaterials, natural, polymers, hydrogels and ceramics. Natural segment is further segmented into alginate, cellulose, chitin, collagen & gelatin, fibrin, hyaluronic acid and silk. Polymers are further segregated into nylon, Polyanhydrides, polycarbonates and polyamides, polyester, Polyetheretherketone (PEEK), Polyethylene terephthalate (PET), polyvinyl chloride and silicone rubber.
Hydrogels segment is further classified into amorphous fluoropolymer, cobalt-chromium, gold, metallic biomaterials, mg based-alloy, platinum alloys, Polymethylmethacrylate (PMMA), silver, stainless steel and titanium & titanium zirconium alloys. Ceramics are further divided into aluminium oxide, calcium phosphate, calcium sulphate, carbon, glass and zirconia.
Depending on the applications the market is segmented by cardiovascular, dental and prosthetic, ophthalmology, orthopaedic/joint reconstruction, spinal, viscosupplementation and other applications. Other applications cover gastroenterology, neurological disorders/central nervous systems, plastic surgery, tissue engineering and urology.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Increasing Geriatric Population
3.1.2 Growing Incidences of Diseases & Graft Transplant Surgeries
3.1.3 Medical Implants and Technological Advancements
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 Implantable Biomaterials Market, By Material
4.1 Immunomodulatory Biomaterials
4.2 Natural
4.3 Polymers
4.4 Hydrogels
4.5 Ceramics
5 Implantable Biomaterials Market, By Application
5.1 Cardiovascular
5.2 Dental and Prosthetic
5.3 Ophthalmology
5.4 Orthopaedic/joint reconstruction
5.5 Spinal
5.6 Viscosupplementation
5.7 Other applications
6 Implantable Biomaterials Market, By Geography
7 Leading Companies
7.1 BASF SE
7.2 Evonik Industries AG
7.3 Bayer AG
7.4 Zimmer Biomet Holdings, Inc.
7.5 Stryker Corporation
7.6 Collagen Matrix, Inc.
7.7 Royal DSM
7.8 E. I. DU PONT DE NEMOURS AND COMPANY
7.9 Covalon Technologies Ltd.
7.10 CAM Bioceramics BV
7.11 Ceradyne, Inc.
7.12 Orthofix Holdings, Inc.
7.13 Carpenter Technology Corporation
7.14 AdvanSource Biomaterials Corporation
7.15 Corbion N.V.
For more information about this report visit http://www.researchandmarkets.com/research/s23bst/implantable
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials


First Western Ship Transits Strait of Hormuz Since Iran War Began
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Apple Turns 50: From Garage Startup to AI Crossroads
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 



